Avenir Management Company, LLC
Follow13F filer, CIK 1866419, NEW YORK, NY
Avenir Management Company, LLC reported $43,787,302 across 4 holdings for the quarter ended 2023-09-30, in a 13F-HR filed 2023-11-14.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001405086-23-000273
- Period
- 2023-09-30
- Reported value
- $43.8M
- Holdings
- 4
- Top 10 weight
- 100%
- New
- 2
- Sold out
- 2
Largest buys vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| KVYOnew | +963,390 | $33.2M |
| FNCHQnew | +45,650 | $236K |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| LTCHexited | -21,435,551 | -$29.8M |
| FINCH THERAPEUTICS GROUP INCexited | -55,445 | -$473K |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q3 2023
Share positions as resolved from 13F-HR 0001405086-23-000273, largest first. % of portfolio is the value over $43,787,302, the sum of the share positions whose value is usable for ratios (method).
Sold out in Q3 2023
Positions in the previous quarter's report that this quarter's report no longer lists.
| Security | Shares before | Value before | Type |
|---|---|---|---|
| LTCHLATCH INC COM | 21,435,551 | $29.8M | shares |
| FINCH THERAPEUTICS GROUP INCFINCH THERAPEUTICS GROUP INC | 55,445 | $473K | shares |
How Q3 2023 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001405086-23-000273 | base | 2023-11-14 | acceptance time not in the bulk data set |
Filings
Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001405086-23-000273 | Quarter ended 2023-09-30 | 2023-11-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001405086-23-000201 | Quarter ended 2023-06-30 | 2023-08-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001405086-23-000120 | Quarter ended 2023-03-31 | 2023-05-15 | acceptance time not in the bulk data set | |
| 13F-HR 0001405086-23-000062 | Quarter ended 2022-12-31 | 2023-02-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001405086-22-000328 | Quarter ended 2022-09-30 | 2022-11-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001405086-22-000235 | Quarter ended 2022-06-30 | 2022-08-15 | acceptance time not in the bulk data set | |
| 13F-HR 0001405086-22-000152 | Quarter ended 2022-03-31 | 2022-05-16 | acceptance time not in the bulk data set | |
| 13F-HR 0001405086-22-000080 | Quarter ended 2021-12-31 | 2022-02-14 | acceptance time not in the bulk data set |